ArticleJournal of hepatocellular carcinoma2025

Safety and Efficacy of TACE Combined with Lenvatinib and Pembrolizumab in Advanced Hepatocellular Carcinoma (BCLC C): A Retrospective Study.

Zeran Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.